Oliver Wyman

Dr. Jennifer Schneider, Livongo’s Chief Medical Officer, discusses high-tech versus high touch, a better way to measure the ROI of innovation, and what’s next around the bend for Livongo.

For more information on our podcast, follow us on Twitter @OWHealthEditor, visit our online healthcare publication at health.oliverwyman.com, and see our full guest roster at https://www.oliverwyman.com/our-expertise/industries/health-life-sciences/oliver-wyman-health-podcasts.html.

Livongo CMO on When High-Tech Meets High Touch

In this podcast, Jack Stoddard, CEO of Patina Health details why primary care must evolve to better meetpatient needs and improve the patient experience.

Jack Stoddard

CEO, Patina Health

Bryce Bach

Partner, Health & Life Sciences, Oliver Wyman

Jack Stoddard has a history of trying to reshape healthcare. Now he is setting his sights on primary care with Patina Health. In this podcast, Stoddard details why primary care must evolve to better meet patient needs and improve the patient experience.


Creating A More Personalized Model For Primary Care

In this podcast, Jack Stoddard, CEO of Patina Health details why primary care must evolve to better meet
patient needs and improve the patient experience.


Civica Rx is poised to broaden its impact on the drug manufacturingsupply chain in 2023 with the opening of its first production plant. Civica’spresident and CEO discusses the company’s business model and plans for thefuture in this podcast.

Marcia Macphearson

Ned McCoy

President and CEO, Civica Rx

Civica Rx is poised to broaden its impact on the drug manufacturing supply chain in 2023 with the opening of its first production plant. Civica’s president and CEO discusses the company’s business model and plans for the future in this podcast. 


Tackling Drug Shortages, High Prices

In this podcast with Oliver Wyman’s Ann Kaplan, Wessler details how specialty careproviders can catch up to primary care when it comes to utilizing telehealth.

Jeff Wessler

Founder and CEO, Heartbeat Health

Ann Kaplan

 Partner, Health & Life Sciences, Oliver Wyman

Telehealth isn’t just for primary care anymore. Specialty care providers are breaking into the arena and offering patients new ways to access care.


Is Specialty Care The Next Frontier For Telemedicine?

In this podcast with Oliver Wyman’s Ann Kaplan, Wessler details how specialty care
providers can catch up to primary care when it comes to utilizing telehealth.


In this podcast, Kelsey Maguire, Managing Director of Sandbox Industries and the Blue Venture Fund and Akshay Agarway, MD, Partner of Oliver Wyman dissect the macroeconomic and microeconomictrends impacting healthcare and investors.

Kelsey Maguire

Managing Director, Sandbox Industries and the Blue Venture Fund

Akshay Agarway, MD

With ongoing economic uncertainty, investors are taking an even harder look at companies before putting up funding.


Bar Is Set Higher For Companies Seeking Investments

In this podcast, Kelsey Maguire, Managing Director of Sandbox Industries and the Blue Venture Fund and Akshay Agarway, MD, Partner of Oliver Wyman dissect the macroeconomic and microeconomic
trends impacting healthcare and investors.


Healthcare needs to redefine what innovation means for care delivery. Implicit in that is an acknowledgement that technology and innovation are not synonymous. Santiago Doria of Oliver Wyman sits down with Ashwini Zenooz of Commure to discuss ways leaders can deploy new technologies to anchor specific goals that put clinicians and patients at the center.

Santiago Doria is a Principal on the Health & Life Sciences team at Oliver

Santiago Doria

Principal, Oliver Wyman

Ashwini Zenooz is Chief Executive Officer of Commure, an information technology company that is aiming to reimagine how healthcare organizations can connect all of their systems and applications.

Ashwini Zenooz

CEO, Commure

Healthcare needs to redefine what innovation means for care delivery. Implicit in that is an acknowledgement that technology and innovation are not synonymous. When deploying new technology or process, leaders need to anchor it to specific goals that put clinicians and patients at the center.


Reinventing The Tech Stack

Santiago Doria of Oliver Wyman sits down with Ashwini Zenooz of Commure to discuss ways leaders can deploy new technologies to anchor specific goals that put clinicians and patients at the center.


Houston Methodist embarked on an ambitious journey to maximize the use of technology to reimagine its workforce model. That includes a virtual ICU, tele-nurses doing patient intake and discharge, and artificial intelligence helping identify staff training needs. It’s resulting in clinicians being able to spend more time at the bedside. Tom Robinson of Oliver Wyman and Roberta Schwartz, CIO of Houston Methodist discuss the organization's mission to build a sustainable workforce.

Tom Robinson is a Partner on the Health & Life Sciences team at Oliver Wyman

Tom Robinson

Partner, Oliver Wyman

Roberta Schwartz is the EVP and CIO of Houston Methodist. Roberta's mission at Houston Method is focused on building a sustainable workforce. 

Roberta Schwartz

Executive Vice President and Chief Innovation Officer, Houston Methodist

Houston Methodist embarked on an ambitious journey to maximize the use of technology to reimagine its workforce model. That includes a virtual ICU, tele-nurses doing patient intake and discharge, and artificial intelligence helping identify staff training needs. It’s resulting in clinicians being able to spend more time at the bedside.


Building A Sustainable Workforce

Tom Robinson of Oliver Wyman and Roberta Schwartz, CIO of Houston Methodist discuss the organization's mission to build a sustainable workforce from integrating creative technology such as, a virtual ICU, tele-nurses doing patient intake and discharge, and artificial intelligence helping identify staff training needs.


Blog

Health and Life Sciences Practice

The Oliver Wyman Health Podcast features conversations with leaders who are pioneering the transformation of the health market. Oliver Wyman’s Health & Life Sciences Practice is a leader in value-based, consumer-centric healthcare, and serves clients in the pharmaceutical, biotechnology, medical devices, provider, and payer sectors. Topics covered in this series include the business challenges of transforming healthcare from volume to value, consumer engagement, consumer experience, digital health, care delivery models, strategy, leadership, and organization.
Oliver Wyman is a global leader in management consulting that combines deep industry knowledge with specialized expertise in strategy, operations, risk management, and organization transformation. Oliver Wyman is a wholly owned subsidiary of Marsh & McLennan Companies [NYSE: MMC].

Livongo CMO on When High-Tech Meets High Touch

DESCRIPTION

Recent Episodes